Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China
· Delayed Price · Currency is CNY 15.08
-0.24 (-1.57%)
Apr 28, 2025, 2:45 PM CST
Shinva Medical Instrument Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | 692.34 | 654 | 500.07 | 556.49 | 234.14 | 861.31 | Upgrade
|
| Depreciation & Amortization | 207.66 | 207.66 | 197.34 | 200.91 | 178.6 | 187.05 | Upgrade
|
| Other Amortization | 50.63 | 50.63 | 43.78 | 52.84 | 16.08 | 43 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.75 | -3.75 | -2.51 | -3.53 | 0.46 | -10.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 12.87 | 12.87 | 2.03 | 4.51 | 24.97 | 28.97 | Upgrade
|
| Loss (Gain) From Sale of Investments | -93.65 | -93.65 | 7.48 | -172.94 | -51.12 | -1,061 | Upgrade
|
| Provision & Write-off of Bad Debts | 116.98 | 116.98 | 64.33 | 35.09 | 82.15 | 75.21 | Upgrade
|
| Other Operating Activities | -295.1 | 67.35 | 84.52 | 103.56 | -272.9 | 191.07 | Upgrade
|
| Change in Accounts Receivable | 6.82 | 6.82 | -329.1 | -145.01 | 2.32 | 307.14 | Upgrade
|
| Change in Inventory | -540.03 | -540.03 | -726.54 | 18.01 | 256.46 | -182.57 | Upgrade
|
| Change in Accounts Payable | 563.58 | 563.58 | 600.94 | 703.35 | 670.27 | 36.76 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | 2.1 | 2.4 | Upgrade
|
| Operating Cash Flow | 706.01 | 1,030 | 388.05 | 1,403 | 1,098 | 630.91 | Upgrade
|
| Operating Cash Flow Growth | -3.25% | 165.46% | -72.33% | 27.72% | 74.05% | -3.42% | Upgrade
|
| Capital Expenditures | -377.03 | -535.77 | -247.58 | -274.36 | -191.33 | -215.78 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.53 | 2.59 | 0.82 | 18.69 | 9.61 | 23.13 | Upgrade
|
| Cash Acquisitions | - | - | 0.67 | - | - | -224.2 | Upgrade
|
| Divestitures | -5.29 | 1.24 | - | 162.48 | 33.97 | 435.3 | Upgrade
|
| Investment in Securities | 2.29 | -4.67 | -40.5 | 205.09 | 11.7 | 85.21 | Upgrade
|
| Other Investing Activities | 30.51 | 16.71 | 5.36 | 10.31 | 2.85 | 20.61 | Upgrade
|
| Investing Cash Flow | -346.98 | -519.9 | -281.22 | 163.89 | -28.39 | 129.28 | Upgrade
|
| Long-Term Debt Issued | - | 1,153 | 1,321 | 1,071 | 2,199 | 3,912 | Upgrade
|
| Long-Term Debt Repaid | - | -1,232 | -1,214 | -2,346 | -2,876 | -4,488 | Upgrade
|
| Net Debt Issued (Repaid) | 173.98 | -78.69 | 106.99 | -1,275 | -676.45 | -575.94 | Upgrade
|
| Issuance of Common Stock | - | 1,276 | 62.46 | - | 0.39 | - | Upgrade
|
| Common Dividends Paid | -319.22 | -103.8 | -96.95 | -128.68 | -183.28 | -203.01 | Upgrade
|
| Other Financing Activities | -109.48 | -27.95 | -44.68 | -4.12 | - | -8.45 | Upgrade
|
| Financing Cash Flow | -267.37 | 1,066 | 27.81 | -1,407 | -859.34 | -787.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.32 | 6.95 | 1.4 | 0.24 | 0.01 | 1.86 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0.01 | - | Upgrade
|
| Net Cash Flow | 97.99 | 1,583 | 136.04 | 159.31 | 210.37 | -25.34 | Upgrade
|
| Free Cash Flow | 328.99 | 494.34 | 140.47 | 1,128 | 906.78 | 415.13 | Upgrade
|
| Free Cash Flow Growth | 84.07% | 251.91% | -87.55% | 24.42% | 118.43% | - | Upgrade
|
| Free Cash Flow Margin | 3.25% | 4.94% | 1.51% | 11.90% | 9.91% | 4.74% | Upgrade
|
| Free Cash Flow Per Share | 0.59 | 0.83 | 0.27 | 2.14 | 1.73 | 0.79 | Upgrade
|
| Cash Income Tax Paid | 421.48 | 419.57 | 486.1 | 546.32 | 405 | 418.46 | Upgrade
|
| Levered Free Cash Flow | 139.01 | 331.06 | 115.25 | 948.4 | 994.11 | 651.91 | Upgrade
|
| Unlevered Free Cash Flow | 164.68 | 360.48 | 150.83 | 996.06 | 1,070 | 759.26 | Upgrade
|
| Change in Net Working Capital | 196.6 | -184.4 | 237.33 | -662.1 | -772.55 | -621.66 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.